rna
molecul
essenti
cellular
inform
transfer
gene
regul
rna
implic
mani
human
diseas
messeng
noncod
rna
contain
highli
structur
element
evid
suggest
mani
structur
import
function
target
rna
small
molecul
offer
opportun
therapeut
modul
numer
cellular
process
includ
link
undrugg
protein
target
despit
promis
current
singl
class
humandesign
small
molecul
target
rna
use
clinic
linezolid
antibiot
howev
grow
number
smallmolecul
rna
ligand
identifi
lead
burgeon
interest
field
discuss
principl
discov
smallmolecul
drug
target
rna
argu
overarch
challeng
identifi
appropri
target
structur
name
diseasecaus
rna
high
inform
content
consequ
appropri
ligandbind
pocket
focu
place
druggabl
bind
site
rna
extens
knowledg
typic
physicochem
properti
druglik
small
molecul
could
enabl
smallmolecul
drug
discoveri
rna
target
becom
roughli
difficult
protein
target
natur
review
drug
discoveri
volum
august
perspect
p
r
n
g
e
r
n
u
r
e
l
e
l
l
r
g
h
r
e
e
r
v
e
natur
review
drug
discoveri
volum
august
p
r
n
g
e
r
n
u
r
e
l
e
l
l
r
g
h
r
e
e
r
v
e
vast
major
smallmolecul
therapeut
clinic
use
target
protein
success
proteintarget
drug
includ
small
molecul
bind
protein
express
human
fig
express
bacteria
virus
infecti
organ
smallmolecul
therapeut
could
extend
modul
rna
landscap
target
macromolecul
would
expand
order
magnitud
exampl
roughli
human
genom
encod
protein
within
roughli
express
human
protein
thought
diseaserel
mean
disrupt
alter
activ
like
therapeut
use
consequ
within
group
diseaserel
protein
mani
term
undrugg
mean
molecul
lack
distinct
cleftlik
motif
small
molecul
bind
high
specif
affin
net
implic
analysi
de
novo
function
directli
rna
fig
one
class
noncod
rna
microrna
wellvalid
therapeut
target
human
probabl
produc
long
noncod
rna
subset
may
eventu
prove
good
drug
target
summari
fraction
ten
thousand
mrna
noncod
rna
target
extent
druggabl
human
genom
could
increas
consider
strong
proof
principl
rnatarget
drug
provid
experi
clinic
trial
use
antisens
oligonucleotid
sever
gain
regulatori
approv
well
preclin
studi
synthet
rna
redirect
cellular
rna
interfer
rnai
machineri
activ
crisprbas
system
depend
approach
employ
possibl
inhibit
upregul
express
particular
mrna
inhibit
noncod
rna
function
target
specif
rna
sequenc
howev
nucleicacidbas
approach
involv
larg
often
highli
charg
molecul
present
deliveri
challeng
given
choic
oligonucleotidebas
therapi
current
hypothet
smallmoleculebas
therapi
target
rna
smallmolecul
therapi
would
prefer
mani
case
number
small
molecul
alter
rna
function
identifi
provid
encourag
evid
rnatarget
smallmolecul
therapeut
could
develop
studi
base
molecul
identifi
natur
system
exampl
mani
rna
riboswitch
regulatori
element
bind
divers
smallmolecul
metabolit
regul
gene
express
character
smallmolecul
antibiot
produc
numer
bacteri
speci
bind
ribosom
rna
interfer
translat
furthermor
grow
number
synthet
monoval
multival
molecul
bind
secondari
structur
element
repeatcontain
rna
shown
modul
biolog
function
progress
help
address
sceptic
rna
could
viabl
smallmolecul
drug
target
key
challeng
remain
address
humandesign
smallmolecul
drug
target
sliver
drug
protein
sliver
human
genom
encod
protein
human
genom
current
approv
proteintarget
drug
interact
therapeut
fewer
gene
product
mean
human
genom
drug
fig
rna
function
central
conduit
inform
transfer
biolog
system
principl
numer
opportun
creat
smallmolecul
therapeut
target
rna
mrna
could
target
protein
gene
product
could
modul
upregul
downregul
translat
effici
alter
mrna
abund
stabil
directli
target
mrna
activ
protein
difficult
drug
undrugg
might
modul
biogenesi
addit
larg
fraction
human
genom
transcrib
noncod
rna
rna
discuss
target
rna
small
molecul
need
immedi
acknowledg
one
current
know
creat
druglik
rnatarget
small
molecul
repeat
scalabl
way
current
singl
humandesign
approv
drug
class
function
bind
rna
molecul
like
nonspecif
intercal
behaviour
case
research
group
develop
seri
relat
compound
includ
singl
repres
exampl
compound
group
first
type
rna
structur
target
tertiari
structur
involv
multipl
close
pack
helic
fig
irregular
usual
bulgecontain
secondari
structur
fig
triplet
repeat
fig
within
structurebas
divis
compound
list
quantit
estim
druglik
qed
score
druglik
first
read
left
right
figur
overal
limit
number
exampl
collect
sever
molecul
target
surviv
motor
neuron
protein
premrna
transactiv
respons
tar
bulg
helix
myoton
dystrophi
type
cug
triplet
repeat
nonetheless
collect
repres
current
state
field
provid
reason
start
point
think
principl
target
rna
specif
potent
small
molecul
four
name
molecul
fig
ribocil
branaplam
repres
current
gold
standard
biolog
effect
small
molecul
target
rna
molecul
target
complex
rna
structur
motif
high
qed
score
notabl
special
case
moreov
molecul
identifi
phenotyp
screen
screen
complet
discov
molecul
function
interact
rna
thu
none
exampl
provid
clear
guidanc
intent
target
rna
small
molecul
linezolid
broadspectrum
antibacteri
agent
bind
larg
subunit
rna
ribosom
appear
interfer
correct
trna
posit
linezolid
special
case
ribosom
highli
abund
cell
small
molecul
target
ribosom
need
achiev
modest
bind
affin
linezolidribosom
equilibrium
dissoci
constant
k
approxim
merck
ribocil
bind
riboflavin
riboswitch
function
rnamedi
regul
gene
express
bacteria
ribocil
mani
attract
featur
unlik
pursu
bacteria
rapidli
develop
resist
drug
ribocil
bear
chemic
similar
natur
metabolit
ligand
alon
linezolid
antibiot
linezolid
tedizolid
fig
view
success
target
rna
therapeut
use
way
small
molecul
requir
three
distinct
compon
identif
rna
rna
motif
diseaserel
function
use
screen
approach
librari
like
identifi
druglik
molecul
appropri
pharmacolog
properti
identif
focu
rna
motif
suffici
structur
sophist
make
like
high
affin
specif
smallmolecul
bind
achiev
date
work
focus
therapeut
wellvalid
target
compon
notabl
recent
focu
screen
rna
target
druglik
lead
compound
compon
howev
critic
view
consider
target
complex
achiev
select
compon
larg
neglect
mind
overview
current
state
smallmolecul
ligand
discoveri
rna
target
instruct
exampl
present
set
hypothes
regard
target
rna
small
molecul
guidelin
achiev
goal
articl
intend
provoc
look
forward
feedback
respons
idea
engend
inspect
wellresearch
classic
review
rnatarget
small
molecul
reveal
effort
find
smallmolecul
ligand
rna
mostli
identifi
highli
basic
thu
posit
charg
physiolog
condit
planar
molecul
capabl
intercal
stack
rna
base
molecul
tend
bind
rna
high
affin
low
select
kind
molecul
often
poor
pharmacolog
properti
includ
low
cellular
uptak
high
toxic
thu
much
earli
work
focus
molecul
decidedli
undruglik
properti
field
rnatarget
ligand
discoveri
chang
rapidli
mani
group
focus
approach
use
strategi
like
identifi
molecul
plausibl
druglik
properti
compil
analys
collect
instruct
molecul
target
rna
activ
cell
cultur
anim
model
human
focus
molecul
reason
druglik
properti
high
potenc
fig
deemphas
aminoglycosid
natur
review
drug
figur
potenti
rnatarget
druggabl
genom
small
fraction
human
genom
success
drug
date
shown
pie
chart
genom
encod
protein
correspond
protein
shown
expand
pie
segment
estim
protein
thought
diseaserel
protein
encod
genom
current
approv
drug
interact
therapeut
protein
encod
human
genom
target
rna
could
expand
proport
human
genom
could
therapeut
target
possibl
rna
target
includ
mrna
encod
diseaserel
protein
character
undrugg
difficult
drug
shown
light
blue
pie
segment
also
noncod
rna
influenc
diseas
correspond
unknown
proport
genom
encod
noncod
rna
repres
major
accomplish
humaniniti
rnatarget
ligand
develop
nonetheless
ribocil
bind
riboswitch
special
case
drug
bind
pocket
natur
flavin
mononucleotid
ligand
thu
rna
predispos
bind
small
molecul
bind
site
novarti
branaplam
origin
call
ptc
therapeut
chemotyp
similar
publicli
share
qualit
way
molecul
appear
bind
rna
duplex
form
rna
target
premrna
probabl
stabil
either
indirectli
directli
protein
compon
review
discoveri
strategi
includ
highthroughput
screen
use
focus
librari
structureinspir
design
fragmentbas
approach
comput
model
compact
multival
molecul
repres
togeth
molecul
fig
strike
us
reason
valid
potenti
rna
smallmolecul
drug
target
howev
except
four
name
compound
fig
molecul
show
defici
one
featur
convent
druglik
molecul
relationship
druglik
potenc
instruct
ligand
two
intrigu
characterist
first
five
six
molecul
target
higherord
tertiari
structur
druglik
infer
compar
qed
score
oral
avail
drug
independ
potenc
fig
circl
green
shade
observ
suggest
abil
identifi
rnatarget
small
molecul
good
druglik
properti
interrel
choic
rna
target
explor
idea
depth
second
compound
target
rna
secondari
structur
repeat
sequenc
difficult
achiev
good
druglik
high
potenc
simultan
inde
molecul
target
secondari
structur
druglik
rna
bind
affin
anticorrel
high
potenc
achiev
undruglik
molecul
fig
squar
diamond
dash
line
moreov
rel
case
author
examin
substanti
number
molecul
ligand
discoveri
programm
observ
structureact
relationship
sar
often
rel
flat
indic
prove
difficult
improv
potenc
lead
molecul
thu
despit
consider
effort
creativ
compound
identifi
date
characterist
known
potent
bioavail
smallmolecul
drug
target
complex
rna
site
known
highspecif
drug
emphas
focus
target
rna
small
molecul
think
requir
identif
cleftcontain
pocketcontain
rna
see
analysi
rule
possibl
lowcomplex
site
larg
multival
ligand
might
prove
therapeut
use
proteintarget
field
compound
would
roughli
analogu
drug
target
proteinprotein
interfac
small
nuclear
ribonucleoprotein
particl
snrnp
compound
programm
test
clinic
trial
discoveri
molecul
impress
achiev
target
site
pocket
includ
protein
compon
neither
strictli
rnatarget
drug
rest
instruct
compound
show
distinct
interest
featur
fig
notabl
molecul
discov
use
wide
varieti
strategi
intent
focus
identifi
rna
target
subset
broadli
druglik
featur
emphas
recent
clinic
use
smallmolecul
drug
physicochem
properti
tend
fall
within
narrow
rang
possibl
valu
compound
molecular
featur
consist
properti
said
druglik
emphas
druglik
import
characterist
provid
use
shorthand
molecul
properti
desir
drug
given
oral
human
includ
solubl
cell
tissu
permeabl
metabol
stabil
lack
toxic
lipinski
rule
five
wellknown
set
criteria
use
evalu
druglik
molecul
rule
deriv
retrospect
analysi
known
drug
drug
candid
lipinski
rule
emphas
molecul
intend
becom
oral
bioavail
drug
larg
molecular
mass
less
da
polar
hydrophob
fewer
five
hydrogenbond
donor
logp
octanolwat
partit
coeffici
less
five
emphasi
five
serv
mnemon
rememb
rule
idea
privileg
chemic
space
recent
extend
quantifi
singl
term
overal
druglik
oral
bioavail
molecul
approach
allow
cutoff
exampl
one
lipinski
rule
broken
overal
molecular
qualiti
compound
high
work
emphas
quantit
estim
druglik
qed
score
qed
score
rang
zero
properti
unfavour
one
properti
favour
qed
continu
function
allow
overal
druglik
molecul
summar
singl
term
show
good
discriminatori
power
correl
intuit
chemic
aesthet
cultiv
medicin
chemist
bioactiv
molecul
high
low
qed
score
shown
figur
median
qed
score
current
oral
bioavail
human
drug
approxim
oral
avail
drug
qed
score
concept
druglik
specif
parameter
qed
cours
primarili
base
smallmolecul
drug
target
protein
success
drug
especi
antibiot
viral
proteas
inhibitor
quit
low
qed
score
low
druglik
profil
rule
potenti
use
smallmolecul
drug
candid
also
possibl
rnatarget
drug
follow
differ
set
principl
target
protein
evid
molecul
bind
rna
differ
structur
kinet
properti
averag
small
molecul
bind
protein
nonetheless
druglik
strongli
influenc
bioavail
human
physiolog
drug
thu
suggest
rnatarget
drug
ultim
follow
roughli
rule
druglik
current
bettercharacter
proteintarget
cousin
constitut
beyond
ruleoff
box
molecul
respect
target
pathogen
repeat
expans
sequenc
exampl
cug
cag
repeat
characterist
huntington
diseas
respect
might
repres
intrigu
special
case
although
trinucleotid
repeat
sequenc
low
complex
appear
contain
obviou
ligand
pocket
see
possibl
cooper
bind
situ
assembl
ligand
driven
suprasecondari
structur
repeat
sequenc
might
afford
critic
specif
select
strategi
may
prove
fruit
gener
expect
notabl
increas
degre
difficulti
noncod
rna
fold
back
form
complex
structur
argu
rna
complex
structur
also
tend
contain
pocket
suffici
structur
sophist
allow
specif
highaffin
bind
small
molecul
rna
binder
druglik
demonstr
analysi
linezolid
ribocil
fig
linezolid
ribocil
unremark
molecul
point
view
convent
medicin
chemistri
consist
lipinski
rule
five
box
low
total
polar
surfac
area
tpsa
consist
good
membran
permeabl
neither
contain
red
flag
toxic
critic
bind
structur
pocket
hypothes
rnatarget
drug
rnatarget
drug
probabl
look
like
convent
proteintarget
drug
one
question
aris
immedi
think
target
rna
small
molecul
whether
structur
differ
rna
protein
render
rna
less
druggabl
protein
rna
compos
four
primari
nucleotid
build
block
much
highli
charg
hydrophil
typic
protein
suggest
focus
global
differ
miss
point
key
issu
drug
rna
whether
rna
form
specif
bind
site
capabl
bind
druglik
molecul
current
evid
suggest
bacteri
target
rna
larg
subunit
bacteri
ribosom
rna
bacteri
flavin
mononucleotid
fmn
riboswitch
respect
fig
ligandbind
site
complex
sens
featur
innerspher
nucleobas
direct
contact
ligand
set
outerspher
nucleotid
rigidifi
support
structur
ligandbind
site
fig
factor
direct
intim
contact
innerspher
nucleotid
support
complex
network
make
bind
site
similar
mani
pocket
protein
target
bind
therapeut
use
small
molecul
comparison
singl
ligand
riboflavin
recogn
protein
rna
support
abil
rna
recogn
divers
physic
featur
ligand
fig
although
riboflavin
tpsa
valu
high
featur
moder
outlier
rel
drug
fact
clinic
use
riboflavin
contain
three
distinct
molecular
entiti
nitrogenrich
twore
system
hydrophob
dimethylbenzen
ring
ribos
group
riboflavin
kinas
protein
flavin
rna
riboswitch
recogn
riboflavin
similar
ident
way
protein
rna
form
multipl
hydrogen
bond
pteridin
ring
system
make
multipl
van
der
waal
contact
dimethylbenzen
ring
form
hydrophob
stack
interact
plane
threer
system
form
hydrogen
bond
hydroxyl
group
ribos
chain
fig
analysi
show
good
rna
target
high
inform
content
overarch
concern
target
rna
achiev
high
bind
affin
high
select
cellular
context
mani
similar
rna
motif
date
substanti
fraction
effort
devot
target
rna
focus
simpl
rna
structur
consist
basepair
helic
irregular
bulgecontain
duplex
fig
contrast
rna
interact
druglik
rnatarget
molecul
linezolid
ribocil
riboflavin
bind
complex
structur
encapsul
cleftlik
site
reminisc
ligandbind
site
protein
fig
complex
rna
character
term
inform
content
measur
bit
one
bit
amount
inform
requir
distinguish
two
possibl
rna
secondari
structur
model
high
accuraci
basi
sequenc
covari
inform
mani
align
sequenc
avail
use
chemic
probe
strategi
select
acyl
analys
primer
extens
shape
enabl
use
estim
inform
content
individu
rna
number
bit
rna
target
approxim
sum
inform
individu
structur
element
box
analysi
inform
content
especi
attract
rna
metric
rel
easi
calcul
given
secondari
structur
model
modest
addit
biochem
inform
provid
imparti
way
evalu
current
futur
target
gener
six
base
pair
rna
helix
inform
content
roughli
bit
wherea
linezolid
ribocil
branaplam
bind
site
probabl
exceed
bit
inform
content
ligandbind
site
reflect
innerspher
outerspher
interact
see
fig
nucleotid
necessarili
touch
rna
ligand
directli
affect
inform
content
site
perhap
instruct
illustr
date
interrelationship
rna
complex
ligand
bind
come
prior
studi
focus
examin
rna
sequenc
identifi
vitro
select
bind
gtp
interact
gtp
rna
probabl
involv
primarili
guanosin
entiti
molecular
mass
da
qed
score
gtp
bind
affin
show
strong
correl
complex
inform
content
rna
target
fig
circl
gtp
increas
inform
content
target
rna
bit
experiment
observ
yield
roughli
increas
bind
affin
term
relationship
breviti
relationship
also
hold
anoth
ligand
affin
versu
target
site
complex
data
avail
fig
diamond
data
ref
line
offset
gtp
line
higher
affin
given
inform
content
gtp
probabl
larger
size
approxim
relationship
identifi
prior
studi
provid
framework
interpret
recent
effort
target
rna
small
molecul
exampl
ribocil
branaplam
lownanomolar
affin
bind
rna
rnaprotein
site
respect
high
inform
content
fig
triangl
similarli
divers
effort
focus
identifi
ligand
target
lowtomoder
inform
contentinclud
stemloop
bit
tar
hairpin
bit
asymmetr
loop
hepat
c
viru
intern
ribosom
entri
site
hcv
ire
element
bit
uniqu
specifi
rna
target
context
human
transcriptom
box
critic
conclus
analysi
inform
content
current
effort
target
rna
druglik
molecul
well
expect
effort
target
rel
simpl
structur
achiev
modest
potenc
result
molecul
affin
rang
micromolar
bind
affin
lowmolecularmass
ligand
agre
close
expect
base
relationship
fig
squar
lowtomoderateaffin
target
site
fall
bit
threshold
roughli
amount
inform
requir
amount
inform
requir
specifi
rna
target
defin
structur
complex
measur
bit
one
bit
correspond
inform
requir
distinguish
two
possibl
exampl
purin
pyrimidin
base
two
bit
therefor
requir
defin
invari
absolut
requir
nucleotid
rna
element
nucleotid
posit
sequenc
constraint
correspond
zero
bit
inform
requir
defin
conserv
base
pair
subtl
degre
mismatch
wobbl
pair
often
allow
canon
watsoncrick
base
pair
allow
gu
correspond
roughli
bit
mani
rna
motif
short
helix
requir
stabil
given
structur
specif
sequenc
length
degre
allow
mismatch
vari
estim
gener
helix
requir
equival
six
base
pair
half
could
wobbl
mismatch
pair
correspond
bit
total
inform
content
given
rna
motif
drug
target
given
sum
inform
content
everi
posit
target
element
see
rna
structur
motif
model
good
accuraci
base
chemic
probe
data
especi
use
select
acyl
analys
primer
extens
shape
strategi
shape
experi
use
reagent
form
coval
adduct
group
rna
degre
reactiv
report
local
nucleotid
flexibl
shape
reactiv
interpret
use
rna
fold
softwar
defin
secondari
structur
rna
target
region
low
versu
high
reactiv
tend
basepair
singlestrand
respect
total
number
bit
rna
target
site
estim
secondari
structur
taken
togeth
addit
biochem
data
exampl
compar
sequenc
analysi
biochem
experi
inspect
interact
observ
highresolut
studi
appli
rule
recognit
transactiv
respons
tar
rna
element
short
transactiv
transcript
tat
deriv
peptid
score
base
inform
content
structur
element
recogn
peptid
reveal
interact
site
contain
bit
inform
shown
figur
box
nucleotid
show
sequenc
specif
bracket
indic
element
structur
sequenc
primari
constraint
use
refer
point
help
calibr
distinct
rna
motif
given
amount
inform
content
exampl
bit
equival
expect
occurr
wherea
bit
correspond
motif
occur
roughli
billion
nucleotid
see
figur
thu
bit
requir
reason
confid
rna
target
uniqu
human
transcriptom
million
billion
select
thu
necessarili
method
use
smallmolecul
molecular
framework
limit
rnatarget
drug
discoveri
field
argu
field
limit
choic
target
without
suffici
complex
inform
content
hypothesi
focus
rna
target
site
high
inform
content
import
order
identifi
site
target
roughli
one
billion
bit
select
necessari
identifi
site
uniqu
complex
transcriptom
order
achiev
high
potenti
determin
target
surfac
requir
preexist
knowledg
put
ligand
pocketfind
strategi
predict
locat
pocket
estim
shape
size
fig
exampl
pocket
riboflavin
kinas
fmn
riboswitch
distinguish
volum
buried
indic
surfac
flat
correspond
complet
buri
pocket
valu
indic
larg
cleftlik
region
fig
similarli
pocket
ribosom
rna
linezolid
bind
larg
highli
buri
fig
strong
contrast
characterist
mani
rna
motif
target
small
molecul
date
contain
would
consid
either
intuit
quantit
notabl
pocket
exampl
helic
contain
cag
cug
trinucleotid
repeat
almost
certainli
repeat
sequenc
contain
featur
meet
common
definit
ligandbind
pocket
rna
motif
compos
primarili
secondari
structur
includ
regulatori
stemloop
microrna
hiv
tar
rev
respons
element
rre
stemloop
contain
small
shallow
pocket
fig
possibl
kind
motif
target
probabl
prove
challeng
much
way
target
shallow
groov
character
mani
proteinprotein
interact
straightforward
identifi
rna
adopt
highqual
probabl
target
structur
simplest
motif
complex
highinformationcont
structur
multihelix
junction
analysi
structur
threehelix
junction
reveal
motif
inform
content
exceed
bit
contain
highqual
pocket
fig
pocket
simpli
consequ
complex
structur
multihelix
junction
occur
wide
larg
rna
mani
known
overlap
occur
within
function
motif
subset
form
welldefin
stabl
structur
element
pseudoknot
simpl
motif
form
unpair
nucleotid
loop
pair
region
outsid
stem
close
loop
mani
pseudoknot
contain
highqual
pocket
illustr
structur
simian
retroviru
type
pseudoknot
form
common
htype
pseudoknot
fig
pseudoknot
thought
rel
rare
larg
rna
appear
overrepres
function
import
region
potenc
discuss
third
critic
advantag
target
complex
site
complex
site
contain
highqual
pocket
ligand
drug
bind
examin
ligandabl
repres
target
term
pocket
qualiti
pocket
predict
algorithm
use
combin
sequenc
structur
ligand
inform
provid
estim
potenti
bind
site
within
target
use
algorithm
pocketfind
estim
qualiti
potenti
ligandbind
pocket
form
repres
set
rna
pocketfind
algorithm
defin
ligandbind
envelop
base
transform
lennardjon
c
ligandbind
pocket
repres
lowtomediumcomplex
target
includ
cag
helic
repeat
pdb
id
stemloop
pdb
id
microrna
mir
pdb
id
hiv
transactiv
respons
tar
pdb
id
rev
respons
element
rre
pdb
id
e
potenti
ligandbind
pocket
high
complex
site
threehelix
junction
pdb
id
simian
retroviru
type
pseudoknot
pdb
id
pocket
qualiti
calcul
use
pocketfind
part
molsoft
packag
fmn
flavin
mononucleotid
first
reiter
one
current
know
target
rna
druglik
small
molecul
scalabl
reproduc
way
proofofprincipl
exampl
exist
fig
druglik
molecul
discov
base
phenotyp
assay
later
found
target
rna
molecul
discov
date
via
strategi
intent
design
target
rna
gener
suffer
tradeoff
druglik
potenc
due
low
inform
content
low
pocket
qualiti
nonetheless
current
exampl
support
fundament
target
rna
suspect
wide
varieti
screen
strategi
includ
phenotyp
assay
highthroughput
screen
fragmentbas
screen
smallmolecul
microarray
biophys
partit
approach
structureinspir
comput
assist
design
eventu
prove
use
light
would
like
propos
follow
guidelin
futur
effort
direct
rnatarget
drug
discoveri
focu
rna
motif
suffici
complex
uniqu
abl
form
highqual
pocket
capabl
bind
smallmolecul
ligand
high
affin
think
good
rna
target
bit
pocket
motif
like
common
larg
rna
posit
good
target
pocket
exist
absenc
high
inform
content
cautiou
earli
attempt
defin
special
privileg
chemic
scaffold
target
rna
might
exist
lot
inform
like
requir
promis
scaffold
defin
instead
emphas
rule
deriv
decad
develop
proteintarget
drug
like
appli
rnatarget
drug
well
deemphas
lesson
ribosom
due
uniqu
high
concentr
cell
ribosom
rna
special
case
engag
expect
ligand
micromolar
affin
target
present
micromolar
concentr
drug
target
ribosom
rna
thu
achiev
uniqu
kind
specif
bind
rel
weakli
ribosom
cautiou
interpret
result
studi
focus
compound
highli
basic
intercal
strongli
stack
andor
highli
hydrophob
kind
compound
may
bind
rna
high
affin
unlik
three
key
compon
necessari
enabl
effect
repeat
scalabl
rnatarget
drug
discoveri
therapeut
compel
rna
target
screen
approach
identifi
druglik
lead
molecul
appropri
pharmacolog
properti
identif
rna
motif
suffici
inform
content
highspecif
highpot
bind
highqual
pocket
achiev
argu
broad
chang
strategi
creat
rnatarget
drug
much
greater
emphasi
need
place
qualiti
rna
target
compon
biolog
wellvalid
rna
target
import
cours
much
greater
effort
need
place
ensur
ligand
target
ultim
learn
constitut
highqual
rna
target
rna
might
prove
difficult
drug
protein
inde
given
target
rna
motif
appear
ubiquit
ref
fig
e
principl
rna
structur
fold
simpler
protein
wonder
rna
might
eventu
prove
gener
target
protein
success
rnatarget
therapeut
discoveri
effort
would
open
vast
opportun
fig
modul
function
current
undrugg
proteinmedi
pathway
noncod
transcriptom
show
strong
discrimin
target
offtarget
site
like
difficult
improv
medicin
chemistri
campaign
target
rnaprotein
interact
rna
element
stabil
protein
bind
branaplam
appear
easi
imagin
recognit
targetspecif
rna
element
conjunct
gener
protein
compon
cellular
metabol
regulatori
network
might
highli
product
strategi
achiev
specif
via
select
rnatarget
compon
affin
owe
high
inform
content
protein
interfac
use
method
enabl
rapid
identif
rna
motif
highinformationcont
structur
highqual
pocket
clear
advantag
rna
protein
tool
quantit
chemic
probe
approach
alreadi
exist
make
possibl
identifi
highinformationcont
structur
welldetermin
lowentropi
target
site
examin
influenc
cellular
environ
specif
rna
structur
ensur
simplifi
screen
construct
recapitul
nativ
rna
motif
develop
addit
tool
new
refin
current
tool
includ
advanc
structur
biolog
model
strategi
rna
complex
structur
technolog
leverag
identifi
rapidli
character
subset
complex
rna
structur
highqual
ligandbind
pocket
rapidli
assess
impact
ligand
bind
function
site
implement
reproduc
strategi
connect
ligand
bind
complex
target
clear
therapeut
mechan
modesttogood
evid
disrupt
stabil
rna
structur
near
translat
initi
site
modul
gene
express
therapeut
use
way
evid
bind
small
molecul
mrna
modul
effici
translat
disrupt
stabil
rnaprotein
interact
therapeut
promis
coval
drug
gain
accept
proteintarget
field
analog
ligand
form
coval
linkag
induc
cleavag
rna
target
site
also
hold
promis
